Dolce first got the idea to visit every Red Cross location after donating platelets at the organization’s Buffalo, New York, ...

The 2025 CSAR Student Award winners were presented with their certificates by Dr Diarmuid O’Brien, the University of ...

EXCLUSIVE: A 20-year study in the US and UK has created an online calculator that can forecast if a rare cancer will made a ...

A new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by pollen. Scientists have found a way to stop allergic reactions caused by ...

Yet exercise can sometimes be deceptive. Years before starting Virta Health, while cofounding the real-estate company Trulia, ...

The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...

It was June 4th of 2024 when a sharp, excruciating pain under my right ribs introduced itself — because clearly, my body ...

Japanese researchers have developed artificial blood, potentially revolutionizing emergency medicine and addressing global ...

NHS GP and ITV's Dr Amir Khan has shared a reason you may be getting colds and infections more regularly than normal, and ...

(NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today ...

A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.

Two separate teams of researchers have found a way to grow blood vessels within lab-grown organs. The creation of miniature organs in the lab, such as tiny replicas of hearts, livers, and lungs, has ...